Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 47.30
-0.70 (-1.46%)
Aug 19, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4.16 billion as of August 19, 2026. Its market cap has decreased by -8.22% in one year.
Market Cap
4.16B
Enterprise Value
6.75B
Revenue
4.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
47.30
ChartMarket Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.16B, an increase of 494.15%. That is a compound annual growth rate of 8.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 4.10B | 5.58% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 6.61B |
| SCI Pharmtech | 6.38B |
| Formosa Laboratories | 6.28B |
| Orient Pharma | 5.36B |
| Panion & Bf Biotech | 5.01B |
| Tien Liang BioTech | 4.12B |
| LIWANLI Innovation | 4.05B |
| Easywell Biomedicals | 3.74B |